Why is Biofil Chemicals falling/rising?

As of 18-Jul, Biofil Chemicals & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 45.80, reflecting a decrease of Rs 2.35 or 4.88%. The stock has underperformed its sector by 4.33% today, opening with a loss of 2.39% and reaching an intraday low of Rs 45.80. Over the past week, the stock has decreased by 3.13%, and it has shown a significant decline of 19.65% year-to-date. The company's weak long-term fundamentals are highlighted by a -20.95% CAGR growth in operating profits over the last five years and a poor EBIT to interest ratio of 0.74, indicating challenges in servicing its debt. Additionally, the stock's return on equity is low at 4.50%, and it has generated a return of -27.93% over the past year, further contributing to its negative price movement.
In the broader market context, the Sensex has shown a slight increase of 0.38% over the past month, contrasting with Biofil Chemicals' decline of 4.60% in the same period. This underperformance is evident as the stock has consistently lagged behind the benchmark, with negative returns over various time frames, including -27.93% in the last year and -13.26% in the last three years. The falling investor participation, with a 90.8% drop in delivery volume compared to the five-day average, suggests a lack of confidence among investors, which is compounded by the company's flat results and declining sales. Overall, these factors indicate a challenging environment for Biofil Chemicals, leading to its current downward price trend.